{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-009606","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.682564+00:00","generated_at":"2026-06-17T09:55:48.562250+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"AIM ImmunoTech appoints Nancy Bryan to Board effective March 28, 2023","bullets":["Nancy Bryan appointed to Board of Directors effective March 28, 2023; also named to Audit, Corporate Governance and Nomination, and Executive Committees.","Bryan is President and CEO of BioFlorida with 25 years of life sciences experience including roles at Merck, GlaxoSmithKline, and Bayer.","Board determined Bryan meets independence standards; she has no material interest in any related-party transactions.","Bryan's appointment adds commercial and marketing expertise as AIM advances Ampligen toward late-stage development."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-009606","json":"https://secwatch.observer/filing/0001493152-23-009606.json","markdown":"https://secwatch.observer/filing/0001493152-23-009606.md","text":"https://secwatch.observer/filing/0001493152-23-009606.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315223009606/0001493152-23-009606-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315223009606/fom8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:55:48.562250+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"266e23e458","claim":"Nancy Bryan was appointed as Director at AIM ImmunoTech Inc..","evidence_excerpt":"On March 30, 2023, AIM ImmunoTech Inc. (the “Company”) issued a press release announcing the appointment of Nancy Bryan to its Board of Directors (the “Board”), effective March 28, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315223009606/0001493152-23-009606-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}